Latest Posts
About This Stock
More About This Stock
Read
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
![](https://talkmarkets.com/user_content/contacts/thumb_F41E341B-7DB4-499D-8099-91A9C1D16F31.jpeg?app=283660)
Article By:
T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Akcea, Ionis Slide After FDA Document Highlights Volanesorsen 'Safety Concerns'
![](https://talkmarkets.com/user_content/contacts/thumb_8CCDEB30-5973-40C5-963F-320E48CC72C6.jpeg?app=214622)
Article By:
The Fly
Tuesday, May 8, 2018 12:51 PM EDT
Shares of Ionis Pharmaceuticals and its majority-owned spinout Akcea Therapeutics are sliding after the Food and Drug Administration posted its briefing document ahead of Thursday's meeting to discuss the latter's volanesorsen.
Novartis-Backed Ionis Subsidiary Akcea Maps A $100M IPO As It Steers A Lead Drug To Regulators
Sounds good to me! $NVS $IONS